INJECTION SITE HAEMORRHAGE

This adverse event was reported 79948 times

These drugs are most commonly taken by patients reporting INJECTION SITE HAEMORRHAGE:

# Drug Count
0 ADALIMUMAB 16320
1 ETANERCEPT 8875
2 TIRZEPATIDE 5540
3 TERIPARATIDE 4517
4 EVOLOCUMAB 4136
5 DULAGLUTIDE 3179
6 INTERFERON BETA-1A 3010
7 METFORMIN 2879
8 METHOTREXATE 2832
9 METHOTREXATE SODIUM 2807
See all common drugs associated with INJECTION SITE HAEMORRHAGE

INJECTION SITE HAEMORRHAGE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TESTOSTERONE ENANTHATE 142 0.0865
1 ADALIMUMAB-ADBM 18 0.0672
2 ERGOCALCIFEROL 1727 0.0581
3 GALCANEZUMAB-GNLM 1666 0.0516
4 TERIPARATIDE 4517 0.0402
5 DULAGLUTIDE 3179 0.0356
6 EXENATIDE 1810 0.0346
7 RILONACEPT 39 0.0337
8 TIRZEPATIDE 5540 0.0306
9 ALIROCUMAB 752 0.0292
See all drugs enriched for association with INJECTION SITE HAEMORRHAGE

INJECTION SITE HAEMORRHAGE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 149 0.2166
1 PCSK9 Inhibitor [EPC] 4864 0.1889
2 Adrenocorticotropic Hormone [EPC] 123 0.1374
3 Provitamin D2 Compound [EPC] 1727 0.0580
4 Interleukin-17A Antagonist [EPC] 1863 0.0500
5 Parathyroid Hormone Analog [EPC] 4517 0.0402
6 Recombinant Human Growth Hormone [EPC] 659 0.0300
7 GLP-1 Receptor Agonist [EPC] 11139 0.0248
8 Guanylate Cyclase-C Agonist [EPC] 45 0.0217
9 Interleukin-23 Antagonist [EPC] 1996 0.0191
See all drug classes enriched for association with INJECTION SITE HAEMORRHAGE